Our purpose
Improve people's lives
Therapeutic areas
Find out more
Contract Manufacturing
Find out more
R&D
Find out more
Patients
Find out moreAbout us
Learn how we've been delivering on our mission for patients for 90 years.
Media
ESTEVE ACQUIRES HRA PHARMA RARE DISEASES
This expands ESTEVE's portfolio of medications for rare and severe diseases with three products to treat Cushing's syndrome and adrenocortical carcinoma; and drives its intern...
10/07/2024
Read moreESTEVE WILL INVEST 100 MILLION EUROS IN THE CONSTRUCTION OF A NEW PLANT AT ITS INDUSTRIAL CENTRE IN CELRÀ (GIRONA)
The company expects the new facilities to be operational in the last quarter of 2026.
This unit will allow the company's production capacity to increase globally ...
28/06/2024
Read moreESTEVE CONSOLIDATES ITS DOUBLE-DIGIT GROWTH AND REACHES �710 MILLION IN NET REVENUE
The company advances in its vision to be a leading international specialty pharmaceutical company, growing in Europe and expanding the portfolio
ESTEVE's medicine...
16/05/2024
Read more
Our global presence
Get our latest news and media resources
Go